Giving children the best possible start in life
Mission
InfanDx's mission is to improve clinical decision making in prenatal and neonatal care through non-invasive, early, and accurate prenatal genetic screening

About Us

InfanDx AG is a privately held company focusing on the development and commercialization of novel diagnostic solutions for child health. Lead by a team of seasoned industry experts, InfanDx initially focused on the development of a test for the early detection of hypoxic-ischemic encephalopathy.

The Company shifted focus in 2023 to non-invasive prenatal screening. Based on a proprietary in-licensed technology InfanDx aims to take non-invasive prenatal testing beyond the current scope of chromosome copy number variations (aneupolodies) and large structural variations of DNA to testing of microdeletions and point mutations causative to a large number of genetic diseases. The initial focus of InfanDx's product pipeline lies on taking functional newborn screening for common monogenetic conditions, the current standard-of-care, to an early prenatal stage by non-invasive prenatal genetic screening.

The Company is headquartered in Cologne, Germany, with a branch office in Berlin, Germany, and a wholly owned subsidiary in Boston, MA, USA.

For more information see here:
Corporate Presentation (pdf)
Leadership Management
InfanDx Team combines seasoned diagnostics industry leaders with high-potentials that are talented experts in their respective disciplines.

Dr. Achim Plum

Chief Executive Officer | Managing Director
read more

Dr. Gunter Weiss

Chief Operating Officer
read more

Nicole Witzmann

Chief Financial Officer
read more

Jordan deVos

Vice President, US Operations
read more

PD Dr. Aisha Munk, MD

Head of Medical Science
read more

Thomas König

Senior Biostatistician
read more

Nadine Istanbullu

Human Resource Manager
read more

Nathaly Schäfer

Corporate Affairs Manager
read more

Noodle vom Dachsfelsen

Corporate Security Officer
read more

Supervisory Board

InfanDx Supervisory Board combines life science industry experts with serial entrepreneurs and investment professionals.

Wolfgang Kintzel

Chairman of the Supervisory Board, CEO Cellbox Solutions
read more

Paul Owsianowski

Active Ownership Capital S.à r.l.
read more

Dr. Jörg Fregien

Managing Director, Life Science Inkubator GmbH
read more

Dr. Wolfgang Schwandner

Owner, Arnika Beteiligungen GmbH
read more

Gerhard Albert

Owner CVG Capital GmbH
read more

Klaus Albrecht

Head of Family Office, Alluti GmbH
read more

Scientific Advisory Board

Our distinguished Scientific Advisory Board provides us with access to unparalleled scientific and clinical expertise in neonatal diagnostics, metabolomics, and biostatistics - on a daily basis.

Prof. Dr. Dr. Peter Bartmann

Emeritus Professor and former Head of the Department of Neonatology and current Head of the Research Group for Longitudinal Studies at University of Bonn, Germany

Prof. Dr. Manon Benders

Professor of Neonatology and Head of Department of Woman & Baby Division and at Wilhelmina Children's hospital, UMC Utrecht, The Netherlands

Prof. Dr. Hans-Peter Deigner

Professor at Institute of Precision Medicine, Furtwangen University, Germany, and Visiting scientist at Fraunhofer Gesellschaft, Institute for Cell Therapy and Immunology, Leipzig, Germany

Prof. Dr. Axel Franz

Head of the Center for Pediatric Clinical Studie and Senior Physician, University Hospital Tuebingen, Germany

Prof. Dr. Lena Hellström-Westas

Professor of Perinatal Medicine, Department of Women’s and Children’s Health, Uppsala University, Sweden

Prof. Dr. Matthias Keller

Chief Physician and Medical Director Children's Hospital Dritter Orden, Passau, Adjunct Professor at the Technical University of Munich

Prof. Dr. Matthias Kohl

Professor and Dean of Studies Precision Medicine Diagnostics, Furtwangen University, Germany

Prof. Neil Marlow, M.D.

Emeritus Professor of Neonatology at UCL EGA Institute for Women's Health, London, United Kingdom, and Director of the MRC-funded EPICure studies

Prof. Dr. Ola Saugstad

Professor at Oslo University Hospital, Norway, and Adjunct Professor of Pediatrics (Neonatology) at Northwestern University, USA

Prof. Dr. Hacer Yapıcıoğlu Yıldızdaş

Division of Neonatology, Department of Pediatrics, Cukurova University, Adana, Turkey

Scientific Advisory

Prof. Dr. Dr. Peter Bartmann

Emeritus Professor and former Head of the Department of Neonatology and current Head of the Research Group for Longitudinal Studies at University of Bonn, Germany
read more

Prof. Dr. Manon Benders

Professor of Neonatology and Head of Department of Woman & Baby Division and at Wilhelmina Children's hospital, UMC Utrecht, The Netherlands
read more

Prof. Dr. Hans-Peter Deigner

Professor at Institute of Precision Medicine, Furtwangen University, Germany, and Visiting scientist at Fraunhofer Gesellschaft, Institute for Cell Therapy and Immunology, Leipzig, Germany
read more

Prof. Dr. Axel Franz

Head of the Center for Pediatric Clinical Studie and Senior Physician, University Hospital Tuebingen, Germany
read more

Prof. Dr. Lena Hellström-Westas

Professor of Perinatal Medicine, Department of Women’s and Children’s Health, Uppsala University, Sweden
read more

Prof. Dr. Matthias Keller

Chief Physician and Medical Director Children's Hospital Dritter Orden, Passau, Adjunct Professor at the Technical University of Munich
read more

Prof. Dr. Matthias Kohl

Professor and Dean of Studies Precision Medicine Diagnostics, Furtwangen University, Germany
read more

Prof. Neil Marlow, M.D.

Emeritus Professor of Neonatology at UCL EGA Institute for Women's Health, London, United Kingdom, and Director of the MRC-funded EPICure studies
read more

Prof. Dr. Ola Saugstad

Professor at Oslo University Hospital, Norway, and Adjunct Professor of Pediatrics (Neonatology) at Northwestern University, USA
read more

Prof. Dr. Hacer Yapıcıoğlu Yıldızdaş

Division of Neonatology, Department of Pediatrics, Cukurova University, Adana, Turkey
read more
Partners
aitiologic

aitiologic is an Austrian precision medicine startup developing ai-powered solutions for early disease detection and targeted therapy. aitiologic builds on patented multi-omics technology originally invented at Siemens Healthineers. InfanDx partners with aitiologic for access to this technology in the field of non-invasive prenatal testing and jointly develops with aitiologic the technology platforms for data generation in the lab and cloud-based data interpretation for multiple disease indications, respectively.

Clinical Partner Network

For our clinical research we rely on an exceptional network of clinical partners coordinated by Prof. Dr. Dr. Peter Bartmann, Children’s Hospital of the University Hospital Bonn (Germany).

aitiologic
Clinical Partner Network
Get the latest Corporate Presentation
Get a concise overview on our company by downloading our Corporate Presentation.